Enhanced recovery pathways (ERP) are rapidly gaining acceptance and use in gynecologic surgery. Studies have shown that patients on an ERP have fewer complications, a shorter length of hospital stay and attain a higher level of satisfaction with their surgical experience.1-2 ERPs utilize patient-centered multidisciplinary teams to optimize patient outcomes through evidence-based best practices in perioperative care.3 The essentials of ERPs include: 1) reducing surgical stress; 2) maintaining normal physiological function perioperatively; and 3) expediting postoperative recovery.1 While originally based in colorectal surgery, these protocols have been expanded to other surgical specialties, including gynecology. In 2016, the ERAS® Society published guidelines for gynecologic/oncology surgery. Several of these guidelines are well-established standards of care, such as skin preparation, antimicrobial prophylaxis, and thromboembolism prevention. Others, however, represent a significant departure from long-standing practices like the avoidance of prolonged fasting, mechanical bowel preparation, and opioid pain medications. The benefits for patients and health care systems at large argue for prompt implementation of ERP protocols. This article reviews both established and more recent guidelines which have been less readily adopted and describes how to incorporate these guidelines into surgical practice.
Education and counseling. Ideally, preparation for surgical recovery begins at the time surgical management is recommended. Educating patients and caregivers on what to expect before and after surgery leads to decreased fear and anxiety.4 Encouraging patients to actively participate in their recovery facilitates improved compliance and outcomes. Counseling is performed by primary surgeons, perioperative nurses, and anesthesiologists, emphasizing day-to-day goals and expectations during the entire perioperative period. Take-home materials such as enhanced recovery brochures provide resources for patients to reference before and after surgery.
Because opioid abuse has become a public health crisis, it is imperative to adequately and responsibly treat pain secondary to surgery. ERPs focus on non-narcotic multimodal
approaches to pain control during the entire perioperative period, with a goal of reducing opioid consumption. Patients should receive counseling on these pain management strategies and education on opioid risks and ways to minimize opioid use after surgery.
Preoperative optimization. Prior to surgery, nutritional status and medical conditions such as diabetes and anemia should be optimized. Optimization allows the body to prepare for the stress of surgery and reduces surgical morbidity.1 An emphasis should be placed on cessation of tobacco and excessive alcohol use for at least 4 weeks prior to surgery to promote wound healing and reduce postoperative complications.5-9
HRT and OCs. Given that long-term hormone replacement therapy and oral combined hormonal contraceptives are risk factors for postoperative thromboembolism, consideration should be given to discontinuation of them prior to surgery. Alternative forms of contraception or transdermal hormone therapies can be substituted in their place. Employ thromboprophylaxis for patients utilizing these therapies at the time of surgery.
Preoperative bowel preparation. A large body of evidence clearly shows that mechanical bowel prep, especially in gynecology, does not improve surgical outcomes.10 Avoid routine use of mechanical bowel preparation for patients undergoing benign gynecologic procedures.
Preoperative fasting and carbohydrate loading. Preoperative intake of solid food up to 6 hours and clear liquids up to 2 hours prior to surgery is safe.11 Carbohydrate loading with a clear fluid containing complex carbohydrates is known to attenuate insulin resistance, minimize protein and muscle loss, and improve patient comfort.12 At the preoperative visit, patients are instructed to drink 3 12-oz. bottles of Clearfast before their scheduled surgical time, with the last bottle to be consumed 2 hours before anesthesia, as noted in the available schedule. If Clearfast is not available, Gatorade can be used as a substitute.
Preanesthetic medications/nausea prophylaxis. Patients commonly experience high levels of anxiety in anticipation of surgery and may be given anxiolytics preoperatively. However, anxiolytics can cause varying levels of sedation, impairing early oral intake and mobilization.13 Avoid use of long-acting anxiolytics prior to surgery with administration of short-acting agents only as necessary. Instead, consider other strategies to reduce anxiety, including an emphasis on preoperative counseling and education.
While ERAS Society guidelines recommend multimodal opioid-sparing analgesics in the postoperative period, the theory of pain pathway sensitization, or “protective analgesia,” argues for preoperative initiation.14 While there is some controversy regarding the role of oral vs intravenous (IV) analgesics, oral analgesics are certainly safe to use preoperatively. Consider beginning multimodal non-opioid analgesics preoperatively including a long-acting oral nonsteroidal anti-inflammatory drug (NSAID) (celecoxib 400 mg), acetaminophen (1000 mg), and possibly gabapentin (300-600 mg). Then continue the use of multimodal non-opioid analgesics as a mainstay of pain control post-operatively.
Postoperative nausea and vomiting (PONV) can impede the recovery process. A focus on multimodal PONV prophylaxis and prevention throughout the perioperative period should be utilized. Restricted use of inhalational anesthetics combined with 3 or more IV antiemetic medications with different mechanisms of action provide additive effects. The most commonly administered antiemetics are: ondansetron
(4 mg), dexamethasone (4-8 mg), droperidol (0.625 mg) and metoclopramide (10-20 mg). For patients with a history of PONV, consider giving an oral dose of the NK1 receptor antagonist, aparepitant (40 mg) preoperatively.